BOXER CAPITAL, LLC
Filing Date
Global Rank
#1,182
/ 7,304
▲ 38
· as of Sep 2024
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+0.4%
Period ended 1 year ago
Filed Nov 14, 2024 · 1y
19 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+78.6%
SPY
+76.8%
Annualised alpha
+0.4%
Max drawdown
−54.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
57 positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Top Position
11.8%
+0.5 pts
Top 5
41.7%
+2.7 pts
Top 10
61.1%
−0.3 pts
HHI
494
Diversified+13
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,639,241,663 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | +250,000 | 907,895 | $15,198,162 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
4 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FATE | Fate Therapeutics Inc | −3,255,000 | 4,960,910 | $17,363,185 | |
| NKTX | Nkarta, Inc. | −1,577,744 | 4,029,606 | $18,213,819 | |
| IPSC | Century Therapeutics, Inc. | −1,001,603 | 3,900,000 | $6,669,000 | |
| PRLD | Prelude Therapeutics Inc | −860,100 | 1,708,187 | $3,535,947 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TIL | Instil Bio, Inc. | 355,500 | $23,932,260 | |
| KYMR | Kymera Therapeutics, Inc. | 450,000 | $21,298,500 | |
| NRIX | Nurix Therapeutics, Inc. | 563,067 | $12,652,115 | |
| QURE | uniQure N.V. | 2,225,000 | $10,969,250 | |
| APGE | Apogee Therapeutics, Inc. | 179,000 | $10,514,460 | |
| TERN | Terns Pharmaceuticals, Inc. | 752,000 | $6,271,680 | |
| SRRK | Scholar Rock Holding Corp | 750,000 | $6,007,500 | |
| SMMT | Summit Therapeutics Inc. | 250,000 | $5,475,000 | |
| BCAX | Bicara Therapeutics Inc. | 135,000 | $3,438,450 | |
| ZURA | Zura Bio Ltd | 300,000 | $1,218,000 | |
| No positions match the current search. | ||||
57 positions ·
$1,639,241,663 total
· as of Sep 30, 2024
Showing 51–57
of 57 positions by value
· page 2 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Held | 2,202,812 | $69,785,084 | 4.26% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Held | 650,000 | $81,178,500 | 4.95% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Held | 2,100,000 | $110,880,000 | 6.76% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Held | 500,000 | $112,255,000 | 6.85% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Held | 1,120,192 | $114,595,641 | 6.99% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 6,448,359 | $151,600,920 | 9.25% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 4,279,464 | $194,073,692 | 11.84% |